Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Taisho Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11023
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, zosyn and palux, pabron, taisho kampo ichoyaku, others. It business segments include self-medication, prescription pharmaceutical, and overseas development. Taisho also sells macrolide antibiotic agent clarith. The company markets its products through distributors in Malaysia, the Philippines, Indonesia, Thailand, Hong Kong, Taiwan, Australia, the US, the UK, Vietnam and China. Taisho is headquartered in Tokyo, Japan.

Taisho Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Polyphor Enters into Research Agreement with Taisho Pharma 10
Taisho Pharma Enters into Distribution Agreement with Biofermin Pharma 11
Licensing Agreements 12
Taisho Pharma Enters into Licensing Agreement with Bayer Yakuhin 12
Asset Transactions 13
Eisai to Acquire Rights of Kolbet from Toyoma Chemical and Taisho Pharma 13
Acquisition 14
Taisho Pharma to Acquire Additional 7.06% Stake in Duoc Hau Giang Pharma 14
Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 15
Taisho Pharma Acquires 24.5% stake in Duoc Hau Giang Pharma 16
Taisho Pharmaceutical Co Ltd – Key Competitors 17
Taisho Pharmaceutical Co Ltd – Key Employees 18
Taisho Pharmaceutical Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Polyphor Enters into Research Agreement with Taisho Pharma 10
Taisho Pharma Enters into Distribution Agreement with Biofermin Pharma 11
Taisho Pharma Enters into Licensing Agreement with Bayer Yakuhin 12
Eisai to Acquire Rights of Kolbet from Toyoma Chemical and Taisho Pharma 13
Taisho Pharma to Acquire Additional 7.06% Stake in Duoc Hau Giang Pharma 14
Taisho Pharma to Acquire Dr. Program from Kyorin Pharma 15
Taisho Pharma Acquires 24.5% stake in Duoc Hau Giang Pharma 16
Taisho Pharmaceutical Co Ltd, Key Competitors 17
Taisho Pharmaceutical Co Ltd, Key Employees 18
Taisho Pharmaceutical Co Ltd, Other Locations 19

List of Figures
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Taisho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taylor-DeJongh Inc:企業の戦略・SWOT・財務情報
    Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report Summary Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • UGL Ltd:企業の戦略的SWOT分析
    UGL Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Dubai Electricity and Water Authority:企業の発電所・SWOT分析2018
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • University of California Berkeley-製薬・医療分野:企業M&A・提携分析
    Summary University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and tra …
  • CITIC Ltd (267):電力:M&Aディール及び事業提携情報
    Summary CITIC Limited (CITIC) is a conglomerate company, operating in financial services, resources and energy, manufacturing, engineering contracting, real estate, and other businesses. Financial services include insurance, trust, security, and banking. Resources and energy comprises electricity ge …
  • PT Kalbe Farma Tbk (KLBF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises br …
  • Trust International Insurance Co. P.L.C.
    Trust International Insurance Co. P.L.C. - Strategy, SWOT and Corporate Finance Report Summary Trust International Insurance Co. P.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Neiman Marcus Group LTD LLC:企業の戦略・SWOT・財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Smith Micro Software Inc (SMSI):企業の財務・戦略的SWOT分析
    Summary Smith Micro Software Inc (Smith Micro) is a software development company that develops productivity and graphic software products for professional artists and general consumers. The company offers products such as NetWise, QuickLink, consumer and CommSuite products. Its NetWise products comp …
  • Samsung Electro-Mechanics Co Ltd (009150):企業の財務・戦略的SWOT分析
    Samsung Electro-Mechanics Co Ltd (009150) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Correvio Pharma Corp (CORV):企業の財務・戦略的SWOT分析
    Correvio Pharma Corp (CORV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tetherex Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Tetherex Pharmaceuticals Corp (Tetherex Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops novel medicines for the treatment of inflammation, thrombosis and tumor metastasis. Its lead pipeline product candidate SelK2, a humanized monoclonal antibody targets a cell …
  • Western Energy Services Corp (WRG):企業の財務・戦略的SWOT分析
    Summary Western Energy Services Corp (Western) is an oilfield service company that offers contract drilling, well services and oilfield rental equipment services. The company offers services through Horizon Drilling, Eagle Well Servicing and Stoneham Drilling Corporation. It also provides rental ser …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NRW Holdings Ltd:企業の戦略・SWOT・財務情報
    NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Empresa Nacional del Petroleo:企業の戦略的SWOT分析
    Empresa Nacional del Petroleo - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • ThyssenKrupp AG:企業のM&A・事業提携・投資動向
    ThyssenKrupp AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThyssenKrupp AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • SandRidge Energy, Inc. (SD):石油・ガス:M&Aディール及び事業提携情報
    Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, the company operates assets in Oklahoma and Kansas. In Rockies, SandRidge operates assets within t …
  • KFG Resources Ltd (KFG):企業の財務・戦略的SWOT分析
    Summary KFG Resources Ltd (KFG) is a petroleum and natural gas exploration company that supplies natural gas. The company produces crude oil and natural gas through its reserves. Its oil and gas reserves are located in Mississippi, Wilcox, and Louisiana. KFG’s Mississippi’s projects comprise Carthag …
  • GP Batteries International Ltd:企業の戦略的SWOT分析
    GP Batteries International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆